Found 470 articles for: "atopic dermatitis"
Successful Treatment of Severe Refractory Atopic Dermatitis with Efalizumab
November 2006 | Volume 5 | Issue 10 | Case Reports | 994 | Copyright © November 2006
Despite multiple therapeutic modalities, treatment of atopic dermatitis with its chronic, relapsing nature remains a challenge. Chronic use of standard therapies is associated with variable efficacy ...
Read MoreClobetasol Propionate 0.05% Lotion in the Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Evaluation versus Clobetasol Propionate Emollient Cream
May 2005 | Volume 4 | Issue 3 | Original Article | 330 | Copyright © May 2005
Atopic dermatitis (AD) is a chronic inflammatory and pruritic skin disorder marked by alternating periods of relapse and remission. This multicenter, randomized, active- and vehicle-controlled, inves...
Read MoreA Multicenter, Randomized, Vehicle-Controlled Clinical Study to Examine the Efficacy and Safety of MAS063DP (Atopiclair™) in the Management of Mild to Moderate Atopic Dermatitis in Adults
March 2006 | Volume 5 | Issue 3 | Original Article | 236 | Copyright © March 2006
Background: MAS063DP cream has received marketing authorization in the US and the European Union for symptom relief of atopic dermatitis (eczema) and contact dermatitis.
Design: A multicente...
Read MoreCounter-Regulatory Balance: Atopic Dermatitis in Patients Undergoing Infliximab Infuson Therapy
May 2004 | Volume 3 | Issue 3 | Case Reports | 315 | Copyright © May 2004
Atopic dermatitis has been characterized as an autoimmune or auto-allergic phenomenon in which environmental allergens resembling human proteins activate auto-reactive T-cells to release pro-inflamma...
Read MoreAtopic Dermatitis : A New Treatment Paradigm Using Pimecrolimus
March 2003 | Volume 2 | Issue 2 | Original Article | 131 | Copyright © March 2003
Atopic dermatitis (AD), often called eczema, is a disease characterized by intense pruritus, erythema, dry skin, and inflammation. Pimecrolimus is a novel steroid-free treatment for AD. Consistently ...
Read MoreA Novel Hydrogel Vehicle Formulated for the Treatment of Atopic Dermatitis
July 2007 | Volume 6 | Issue 7 | Original Article | 718 | Copyright © July 2007
Atopic dermatitis (AD) is a chronic cyclical inflammatory skin disease that is increasing in incidence. Twenty percent of those affected with AD are infants and young children. Despite the developmen...
Read MoreA Multiple-Domain Framework of Clinical, Economic, and Patient-Reported Outcomes for Evaluating Benefits of Intervention in Atopic Dermatitis
April 2007 | Volume 6 | Issue 4 | Original Article | 416 | Copyright © April 2007
Atopic dermatitis (AD) increases health care utilization, affects patient quality of life, places a burden on caregivers, decreases patient/parent productivity, and adds to health care costs. Few stu...
Read MorePediatric Acne: Clinical Presentations, Evaluation, and Management
June 2007 | Volume 6 | Issue 6 | Original Article | 589 | Copyright © June 2007
Acne vulgaris can be easy to diagnose yet difficult to evaluate and manage, especially when it presents in infancy and childhood. The differential diagnosis of acne varies by age and, in some cases, ...
Read MorePharmacokinetics of Tacrolimus Following Topical Application of Tacrolimus Ointment in Adult and Pediatric Patients with Moderate to Severe Atopic Dermatitis
February 2007 | Volume 6 | Issue 2 | Original Article | 185 | Copyright © February 2007
Objective: To characterize the pharmacokinetics of tacrolimus after topical application in adult and pediatric patients with moderate to severe atopic dermatitis from all clinical trials in which tac...
Read MoreSafety and Efficacy of Desonide Hydrogel 0.05% in Pediatric Subjects with Atopic Dermatitis
February 2007 | Volume 6 | Issue 2 | Original Article | 175 | Copyright © February 2007
Low to mid potency corticosteroids remain a cornerstone of therapy for atopic dermatitis (AD). Since AD is most prevalent in the younger pediatric population and is chronic in nature, safety is of pa...
Read More